criteria but of all patients declined to seen; they are be enrolled relevant to assessment of external validity only, and they are often not available. Randomisation Participants Crucial count randomly for defining assigned trial size and assessing whether a trial has been analysed by intention to treat. Treatment Participants Participants Important allocation who who did counts for received not receive assessment of treatment treatment internal as as validity and allocated, allocated, interpretation by study by study of results; group group reasons for not receiving treatment as allocated should be given. Follow-up Participants Participants Important who who did counts for completed not assessment of treatment complete internal as treatment validity and allocated, as interpretation by study allocated, of results; group by study reasons for group not Participants Participants completing who who did treatment or completed not follow-up follow-up complete should be as planned, follow-up given. by as planned, group by study group Analysis Participants Participants Crucial included in excluded for assessing main from main whether a analysis, by analysis, by trial has been group group analysed by
criteria but declined to be enrolled of all patients seen; they are relevant to assessment of external validity only, and they are often not available. Randomisation Participants randomly assigned Crucial count for defining trial size and assessing whether a trial has been analysed by intention to treat. Treatment allocation Participants who received treatment as allocated, by study group Participants who did not receive treatment as allocated, by study group Important counts for assessment of internal validity and interpretation of results; reasons for not receiving treatment as allocated should be given. Follow-up Participants who completed treatment as allocated, by study group Participants who did not complete treatment as allocated, by study group Important counts for assessment of internal validity and interpretation of results; reasons for not completing treatment or follow-up should be given. Participants who completed follow-up as planned, by group Participants who did not complete follow-up as planned, by study group Analysis Participants included in main analysis, by group Participants excluded from main analysis, by group Crucial for assessing whether a trial has been analysed by
CONSORT%20checklist%20%202010.docx